Skip Navigation


JAC Advance Access originally published online on May 30, 2006
Journal of Antimicrobial Chemotherapy 2006 58(2):243-255; doi:10.1093/jac/dkl210
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
58/2/243    most recent
dkl210v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gibreel, A.
Right arrow Articles by Taylor, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibreel, A.
Right arrow Articles by Taylor, D. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Reviews

Macrolide resistance in Campylobacter jejuni and Campylobacter coli

Amera Gibreel and Diane E. Taylor*

Department of Medical Microbiology and Immunology, University of Alberta Edmonton, Alberta, Canada

*Corresponding author. Tel: +1-780-492-4777; Fax: +1-780-492-7521; E-mail: diane.taylor{at}ualberta.ca

Infection with Campylobacter jejuni is now considered to be the most common cause of acute bacterial gastroenteritis in humans worldwide. It occurs more frequently than infections caused by Salmonella species, Shigella species, or Escherichia coli O157:H7. Although C. jejuni is also recognized for its association with serious post-infection neurological complications, most patients with C. jejuni infections have a self-limited illness. Nevertheless, a substantial proportion of these infections are treated with antibiotics. These include severe and prolonged cases of enteritis, infections in immune-suppressed patients, septicaemia and other extra-intestinal infections. Under these circumstances, erythromycin is often recommended as the drug of first choice. However, erythromycin-resistant Campylobacter have emerged during therapy with macrolides. Moreover, the widespread use of macrolides, including erythromycin, in veterinary medicine has accelerated this resistance trend. Several countries including Canada, Japan and Finland have reported C. jejuni isolates with low and stable rates of macrolide resistance. In contrast, the increasing level of macrolide resistance in C. jejuni is becoming a major public health concern in other parts of the world such as the United States, Europe and Taiwan. Macrolide resistance in Campylobacter is mainly associated with point mutation(s) occurring in the peptidyl-encoding region in domain V of the 23S rRNA gene, the target of macrolides. Several rapid and practical techniques have recently been developed for the identification of macrolide-resistant isolates of C. jejuni. The aim of this mini-review is to give an overview of the worldwide distribution of macrolide resistance in C. jejuni and Campylobacter coli as well as its possible association with the massive use of these agents in food animals. Mechanisms implicated in macrolide resistance in C. jejuni and also techniques that have been developed for the efficient detection of macrolide-associated mutation(s) will be discussed in detail.

Keywords: erythromycin , campylobacteriosis , ribosomal mutations , efflux systems , efflux pump inhibitors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Appl. Environ. Microbiol.Home page
L. Wang, B. Jeon, O. Sahin, and Q. Zhang
Identification of an Arsenic Resistance and Arsenic-Sensing System in Campylobacter jejuni
Appl. Envir. Microbiol., August 1, 2009; 75(15): 5064 - 5073.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
B. Jeon, W. Muraoka, A. Scupham, and Q. Zhang
Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni
J. Antimicrob. Chemother., March 1, 2009; 63(3): 462 - 468.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
M. Haas, A. Essig, E. Bartelt, and S. Poppert
Detection of Resistance to Macrolides in Thermotolerant Campylobacter Species by Fluorescence In Situ Hybridization
J. Clin. Microbiol., November 1, 2008; 46(11): 3842 - 3844.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. B. Caldwell, Y. Wang, and J. Lin
Development, Stability, and Molecular Mechanisms of Macrolide Resistance in Campylobacter jejuni
Antimicrob. Agents Chemother., November 1, 2008; 52(11): 3947 - 3954.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
L. J. V. Piddock, D. Griggs, M. M. Johnson, V. Ricci, N. C. Elviss, L. K. Williams, F. Jorgensen, S. A. Chisholm, A. J. Lawson, C. Swift, et al.
Persistence of Campylobacter species, strain types, antibiotic resistance and mechanisms of tetracycline resistance in poultry flocks treated with chlortetracycline
J. Antimicrob. Chemother., August 1, 2008; 62(2): 303 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
B. Jeon, W. Muraoka, O. Sahin, and Q. Zhang
Role of Cj1211 in Natural Transformation and Transfer of Antibiotic Resistance Determinants in Campylobacter jejuni
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2699 - 2708.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
T. Quinn, J.-M. Bolla, J.-M. Pages, and S. Fanning
Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection?
J. Antimicrob. Chemother., June 1, 2007; 59(6): 1230 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Lin, M. Yan, O. Sahin, S. Pereira, Y.-J. Chang, and Q. Zhang
Effect of Macrolide Usage on Emergence of Erythromycin-Resistant Campylobacter Isolates in Chickens
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1678 - 1686.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.